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Brain development in mammals is long lasting. It begins early during embryonic growth
and is finalized in early adulthood. This progression represents a delicate choreography of
molecular, cellular, and physiological processes initiated and directed by the fetal genotype
in close interaction with environment. Not surprisingly, most aberrations in brain func-
tioning including intellectual disability (ID) are attributed to either gene(s), or environment
or the interaction of the two. The ensuing complexity has made the assessment of this
choreography, ever challenging. A model to assess this complexity has used a mouse
model (C57BL/6J or B6) that is subjected to prenatal alcohol exposure. The resulting pups
show learning and memory deficits similar to patients with fetal alcohol spectrum disorder
(FASD), which is associated with life-long changes in gene expression. Interestingly, this
change in gene expression underlies epigenetic processes including DNA methylation and
miRNAs.This paradigm is applicable to ethanol exposure at different developmental times
(binge at trimesters 1, 2, and 3 as well as continuous preference drinking (70%) of 10%
alcohol by B6 females during pregnancy).The exposure leads to life-long changes in neural
epigenetic marks, gene expression, and a variety of defects in neurodevelopment and
CNS function. We argue that this cascade may be reversed postnatally via drugs, chemi-
cals, and environment including maternal care. Such conclusions are supported by two sets
of results. First, antipsychotic drugs that are used to treat ID including psychosis function
via changes in DNA methylation, a major epigenetic mark. Second, post-natal environment
may improve (with enriched environments) or worsen (with negative and maternal separa-
tion stress) the cognitive ability of pups that were prenatally exposed to ethanol as well as
their matched controls. In this review, we will discuss operational epigenetic mechanisms
involved in the development of intellectual ability/disability in response to alcohol during
prenatal or post-natal development. In doing so, we will explore the potential of epigenetic
manipulation in the treatment of FASD and related disorders implicated in ID.
Keywords: neurodevelopment, fetal alcohol spectrum disorders,mousemodels, epigenetics, stress, environmental
enrichment, intellectual disability, gene expression
INTELLECTUAL DISABILITY
Mental retardation is a highly diverse group of cognitive disor-
ders. The fifth edition of the Diagnostic and Statistical Manual of
Mental Disorders (5th ed.; DSM -5) characterizes mental retarda-
tion [revised as Intellectual Disability (ID) in the fifth edition)
by impairments of general mental abilities that fall under the
conceptual, social, and practical domains of adaptive function-
ing. Individuals with ID have intelligence quotient (IQ) scores
below 70, approximately two standard deviations or more below
the population average score (1). They represent 1–3% of the pop-
ulation in Canada, and males are affected more often than females
(2). Roughly two-thirds of ID individuals have mild-to-moderate
impairments while the remaining third are severely affected (2). In
2006, the Participation and Activity Limitation Survey by Statistics
Canada, found the largest proportion of ID occurs in the 15–24
age group (29.3%) (2). The survey also found that compared to
individuals with physical disabilities (52.7%), people with intel-
lectual disabilities are far less likely to be employed (26.1%) with
an inverse trend of socio-economic status with respect to preva-
lence (2). In America, the lifetime costs are expected to be near $50
billion for individuals born in 2000 with ID (3).
Intellectual disability and its variable manifestations are often
attributed to aberrations in neurodevelopment that are complex,
poorly understood, and long lasting in mammals. It begins early
during embryonic development but may take years to complete
and is finalized in early adulthood. Further, it involves a delicate
choreography of cellular, molecular, and physiological processes
directed by the fetal genotype in close interaction with the envi-
ronment at every step, over time. Consequently, it covers peri-
ods before birth, during birth, and/or the childhood years. The
causes of ID are complex and multifactorial. In some rare cases,
the primary determinants of ID are known. For example, rare
chromosome number defects [Down syndrome (4, 5)], inherited
chromosomal disorders [Fragile X syndrome (6)], and a number
of single gene mutations (7–9) are known to cause a spectrum
of intellectual. Unfortunately, ID tends to be heterogeneous with
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a wide spectrum of manifestations. Additionally, neurodevelop-
mental exposure to a variety of drugs and chemicals can result in
ID, such as cocaine, alcohol, and lead, among others (10). ID is
not a single disorder, rather the result of a plethora of causations
involving both genes and environment. The understanding of the
developmental processes associated with ID and related abnor-
malities calls for a research focus on specific diagnosis potentially
caused by a single known factor, an experimental model that is
easier to manipulate and interpret. In this discussion, we will use
fetal alcohol spectrum disorders (FASD) as a case study of the
complexity of ID.
FETAL ALCOHOL SPECTRUM DISORDERS
Fetal alcohol spectrum disorder with all its manifestations results
from a single initial cause, prenatal alcohol exposure (PAE). It
includes mild behavioral and learning impairments, to the most
severe form called Fetal Alcohol Syndrome (FAS). FAS may include
ID as well as birth defects (11). The intellectual deficits in FAS and
FASD are highly variable and heterogeneous. These symptoms are
considered chronic, often co-occurring with other mental impair-
ments, and manifesting during the developmental period. FASD
represents one of the most common causes of learning disabili-
ties, cognitive deficits, and ID (12). The severity of impairments is
evaluated using both clinical assessments and standardized testing
of intelligence.
Obtaining a diagnosis of FASD requires input from various
medical professionals, with estimated costs associated with the
diagnostic procedure up to $7.3 million per year in Canada (13).
Unfortunately, despite increasing public education on the dangers
of PAE, the occurrence of alcohol exposed pregnancies remains a
significant societal problem. In Canada, 74.4% of women surveys
reported alcohol use in the past year (14). Most disappointing is the
prevalence of PAE in certain high-risk groups. In Fort McMurray,
Alberta, almost 50% of pregnant women surveyed reported con-
suming an alcoholic beverage since learning of their pregnancy
(15). In a survey of women in Arctic Quebec, over 60% of women
reported alcohol consumption during pregnancy (16). While the
rates of PAE are often considered high, not every reported inci-
dent of alcohol exposure results in FASD. In Canada, the more
severe FAS is estimated to occur at rates of 1–2 per 1000 live births
(17), while the more mild FASD occurs much more often, at a rate
of 9 per 1000 (18). In northeastern Manitoba, estimates of FASD
incidence are as high as 14.8 per 1000 births (19). Children enter-
ing child care systems, such as foster care and orphanages, also
represent a subpopulation with higher incidence of FASD, with
estimates at 60 per 1000 children (20). A 2010 study found that
48% of pregnancies in the United States were unintended (21),
and over 30% of women reported consuming alcohol while preg-
nant (22). The Centre for Disease Control and Prevention reports
FAS rates in the USA ranging from 0.2 to 1.5 per 1000 live births
solidifying the position of FAS as one of the leading preventable
causes of intellectual disabilities (23).
How neurodevelopmental alcohol exposure may cause ID is
poorly understood. It is a critical area of research. Such studies
are not always feasible in humans. In this review, we will present
arguments to suggest that studies on the mechanisms in the devel-
opment of intellectual disabilities could be modeled in suitable
animal models using PAE. It allows coverage of prenatal as well as
post-natal development. Specifically, we will focus on behavioral
data to show that B6 mice offer an opportunity to assess the effect
of neurodevelopmental time specific PAE on molecular processes
that are affected by alcohol and may lead to the manifestation
of ID and related abnormalities. Additionally, it allows controlled
post-natal manipulation (negative stress or positive enrichment)
on the manifestation of mental deficits in pups generated with and
without PAE.
MOUSE MODEL OF FASD RESEARCH
It is understandable that most research on the mechanisms
involved in the development of FASD has concentrated on ani-
mal models, particularly mice (24–27). To this end, our laboratory
has established two forms of neurodevelopmental in vivo alco-
hol treatment in B6 mice. The first uses injections at any time
during neurodevelopment on time-mated females and the second
uses free choice of 10% alcohol or water as the source of liquid
for pregnant females. The pregnant B6 mothers prefer (~70%) to
drink a 10% ethanol in water solution over water. The two meth-
ods equate to the two forms of PAE in humans; binge (injection)
at any time during pregnancy and continuous maternal drink-
ing (preference) during pregnancy. The resultant pups from the
two treatments show alcohol specific phenotypes; developmental
delays, increased anxiety, learning deficits, and pronounced deficits
in visuo-spatial memory (27–29). They also exhibit delayed neural
reflexes, aberrant limbic coordination, elevated levels of anxiety,
and spatial-memory deficits (27). To better ascertain the effects
of ethanol on critical neurodevelopmental time points, we have
mimicked binge-like drinking episodes at critical times, represent-
ing equivalents to the three trimesters in humans. The trimester
three equivalent represents a “brain growth spurt” – dominated
by synaptogenesis during the first 2 weeks in B6 newborn pups
(29, 30). It is a period marked by the formation of extensive
neural connections that form the basis for much of the cell-to-cell
communication in the brain. The ability of ethanol to trigger wide-
spread neurodegeneration during synaptogenesis is accompanied
by the upregulation of stress-related and apoptosis-related genes
and a down-regulation of genes related to protein synthesis, mito-
sis, synaptic formation, and maintenance (28, 30, 31). The third
trimester equivalent ethanol exposure also results in increased
anxiety-like behavioral traits and pronounced recognition mem-
ory and visuo-spatial memory defects (29). The results show that
most PAE treatments in B6 mice cause developmental as well as
behavioral deficiencies that are compatible with manifestations of
FASD. Additional studies regarding timing of ethanol exposure
have found exposure during the first trimester equivalent leads to
decreases in cerebellar volume, while second trimester equivalent
exposure leads to decreased hippocampal volume (32). The model
also allows further studies on specific brain regions that may offer
novel insights. The hippocampus is one of the brain regions that
may be important in the understanding of the complexity of FASD
phenotypes. The primary role of the hippocampus is memory
consolidation (33), emphasized by hippocampal lesions leading to
impaired spatial learning in mice (34). PAE leads to learning and
memory deficits via changes in the hippocampus (35). Ultimately,
some of the behavioral effects of PAE may be a result of molecular
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changes in the hippocampus. The molecular effects of PAE have
been well characterized using animal models under a plethora
of conditions (various neurodevelopmental stages and different
dosages of alcohol) and all of them have shown that PAE affects
epigenetic and genetic processes and various neurodevelopmental
pathways (36–38). A single (or in most cases, multiple) instance of
alcohol exposure during fetal development can result in a lifetime
of behavioral and cognitive deficits. Such results show that PAE
treatments in B6 mice cause deficiencies that are comparable to
the manifestations of FASD in humans.
MOLECULAR ETIOLOGY OF FASD: GENE EXPRESSION AND
EPIGENETIC MARKS
The development of genomic technologies has allowed the search
for molecular mechanisms underlying deficits following PAE. In
both cultured neurons and in vivo evidence, ethanol has been
shown to induce programed cell death 4 (PDCD4) protein syn-
thesis, ultimately resulting in neuronal growth abnormalities in a
rat model of PAE (39). Ethanol has also been shown to induce
apoptosis via ceramide pathways, alongside stress-related kinases
during development in cultured rat astrocytes (40). Direct treat-
ment of ethanol on cultured neural stem cells often results in a host
of changes at the level of gene expression. It includesDnmt1,Uhrf1,
Ehmt1,Ash2 l,Wdr5, and Kdm1b transcripts that have been shown
to have significantly different levels of gene expression following
ethanol exposure in vitro (41).
We have attempted such studies on B6 in vivo (42). The results
show that multiple ethanol-treatment paradigms that result in
FASD phenotypes also show changes in gene expression (28, 30).
Such changes occur with respect to neurodevelopmental timing
of exposure. More important they are representative of genomic
alterations that are dependent on the biological processes occur-
ring at the time of ethanol exposure (30, 42). Interestingly, ethanol
exposure initiates alterations in a set of genes (short-term effect)
that primarily affect cellular compromise and apoptosis repre-
sentative of ethanol’s toxic effects. In the long term, however,
genes affected following PAE are very different and involve vari-
ous cellular functions including epigenetic processes such as DNA
methylation, histone modifications, and non-coding RNA regu-
lation that may underlie long-term changes to gene expression
patterns (43). These may be initiated by ethanol-induced alter-
ations to DNA and histone methylation, particularly in imprinted
regions of the genome, affecting transcription, which is further
fine-tuned by altered microRNA (44). These processes are likely
complex, genome-wide, and interrelated. The epigenetic changes
may be responsible for the FASD-related alterations in gene expres-
sion. Additionally, the epigenetic changes acquired may remain
stable for life and maintain the manifestation of FASD.
At least two features of this system are encouraging and offer
hope for people affected with FASD and related disorders. First,
human brain development is not complete at birth, rather it
continues for decades. More important, the neurodevelopment
during this period is rather malleable and responsive to post-
natal environment. Consequently, it may provide an opportunity
to direct/maneuver post-natal brain development and alter the
course of development of FASD and related endophenotypes. Sec-
ond, the underlying epigenetic changes brought about by PAE
represent an adjustable process. Specifically, DNA methylation is
known to be reversible, and may be altered using different strate-
gies. This promise and hope offered by the two features (continuity
of brain development after birth and potential to change PAE epi-
genetic marks) have remained poorly explored in FASD-related
studies. We will present preliminary results to argue that the con-
tinuum of post-natal neurodevelopment offers an opportunity to
ameliorate the effect of prenatal alcohol and adjust/restore the
final outcome.
POST-NATAL ENVIRONMENT NEURODEVELOPMENT AND
FUNCTIONING
Mammalian neurodevelopment is a long-lasting continuum. It
begins early and finalized in early adulthood. It is also closely
orchestrated and sensitive to prenatal as well as post-natal envi-
ronment, particularly stresses. It makes it nimble with potential
to incorporate desirable post-natal experiences. The mechanism
behind this potential although recognized is not fully understood.
What is known is that post-natal processes contribute to the life-
long changes in behaviors and mental abilities. Also, it may result
via responsiveness of the hypothalamic–pituitary–adrenal (HPA)
axis (45), the primary physiological regulator of the environmen-
tal stress in mammals. Perhaps, the strongest evidence for this
effect comes from post-natal handling of rodents. It involves daily
separation of pups from the mother (3–15 min), a stressful event,
for the first few weeks of life. Such pups show decreased stress
reactivity in adulthood (46–48). Also, pups exposed to extended
positive maternal care show decreased fearfulness and more mod-
est HPA responses to stress (49, 50). Similar results have also been
reported in non-human primates (51), and humans (52, 53). In
each case, variations in post-natal conditions promote hippocam-
pal synaptogenesis and spatial learning and memory through
systems known to mediate experience-dependent neural devel-
opment (54). The question of how post-natal environment causes
such a dramatic effect in mammals has formed a fruitful area of
research in recent years. It argues that this effect may be realized
via the effectiveness of HPA axis.
An underlying mechanism behind the effect of post-natal envi-
ronment is provided by studies by Michael Meaney and his col-
laborators. They found that increased licking and nursing by rat
mothers altered DNA methylation of hippocampal glucocorticoid
receptor in the pups. Further, the altered methylation is directly
related to the development of HPA responses to stresses through
tissue specific effects on gene expression (55). The results also
emphasize that there is a critical period for such effects to be real-
ized. It is particularly effective in early post-natal periods. This
relationship between maternal care and gene expression via DNA
methylation argues for environmental reprograming that is stable
and may form the basis for the developmental origin of vulner-
ability to defects (56). These results have now been replicated in
a number of mammals including humans. They argue that early
life events can alter the methylation (epigenetic) state of relevant
genomic regions, the expression of which may contribute to indi-
vidual differences in the risk for pathology and diseases of fetal
origin (57). Given this understanding, it is natural to consider
post-natal enrichment in correction of any epigenetic pathology.
It is particularly relevant in cases of FASD that are caused by
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alcohol-induced alterations in DNA methylation. In fact, one may
postulate potential involvement of DNA methylation (58) at every
step in neurodevelopment including responses to environment
prenatally as well as postnatally.
The results available have allowed us to propose alterations in
the sequential continuum of neurodevelopment in FASD over a
longer time frame – from fertilization to maturity (Figure 1). It
shows the continuum of neural development with and without
prenatal alcohol that result in metabolomic changes leading to
either FASD or not. It recognizes that the manifestation of this
outcome is not fixed. It must follow additional development and
refinement in a given post-natal environment. Once again, post-
natal environment may affect the developing brain via epigenetic
and metabolomic alterations. We argue that such alterations will
vary and depend on the nature (heavily enriched to heavily stress-
ful) of the post-natal environment. Consequently, the effect of
post-natal environment may permit recovery from prenatal effects
[enriched environments (EE)] or add additional defects (stressful
environment). The model covers molecular processes that underlie
the initiation, progression, and completion of neurodevelopment
and any role prenatal or post-natal stress may have during ges-
tation, birth, and post-natal development. The model recognizes
that the effect of post-natal environment is not restricted to cases
with PAE. Rather, it is expected to have an impact on cases where
there is no exposure to alcohol. Further, although the nature of
prenatal stress is well defined, the nature of post-natal environ-
ment that will have a positive and negative effect remains rather
generic and needs to be carefully investigated. We will discuss this
model further using ongoing experiments.
ASSESSING THE POST-NATAL ENVIRONMENT ON FASD
Fetuses exposed to alcohol prenatally have poor growth in the
womb. Consequently, they are born with low birth weight (59).
Further, almost none of such babies have normal brain develop-
ment. They also show decreased muscle tone, poor coordination,
and slow growth rate (59). Naturally, newborns with FASD are
dependent on post-natal care by the mother for their future devel-
opment. Also, they are often born in suboptimal families and
raised in suboptimal conditions, particularly in the previously
outlined high-risk subpopulations. Consequently, an unfavorable
post-natal environment often provides a continuation of prena-
tal developmental insults thereby increasing the risk and severity
of the PAE outcome. It has been argued that an enriched post-
natal environment may have an ameliorating effect on the brain
development in the FASD babies but the effect of post-natal envi-
ronment on the development of FASD phenotypes has not been
adequately explored. We will assess the results of stressful and
enriched post-natal environment on the growth,development,and
mental ability of newborns with diagnosed with FASD.
STRESSFUL POST-NATAL ENVIRONMENT IN FASD
Results available in the literature argue that the combined effect
of PAE and post-natal stress worsen the behavioral and structural
effects of alcohol exposure alone (60, 61). Further accumulative
stressors over time may contribute to increased risk of depression
in FASD via HPA axis dysregulation (62). In humans, there are
sex-differences in stress regulation, in that females show greater
changes in heart rate, while males exhibit more alterations in
cortisol levels (63). In primates, the combination of PAE and
maternal stress led to a reduction in birth weight in males, but
not females – further highlighting the sex-specificity. Additionally,
both sexes show HPA axis responses following maternal separation
stress (64). In rodent models of PAE, the basal levels of corti-
costerone and adrenocorticotropin (stress-related molecules) are
unaltered, but subjects are hyper-responsive to stressors in adult-
hood (65). Chronic stress leads to increases in corticosterone in
ethanol exposed females following an acute stress event (66), and
prolonged exposure to stressors in ethanol exposed males leads
to overactive HPA response (65). In B6 mice, maternal separation
stress on normal pups is often used to model chronic early life
stress. It uses 3 h of separation per day from post-natal days 2–
14 that can result in anxiety-like behaviors in adult mice (67).
The resulting mice display increased anxiety-like behaviors on
open-field testing (68) similar to those observed in PAE models
without maternal separation. Interestingly, behavioral abnormal-
ities including learning and memory deficits induced by PAE and
prenatal stress may be moderated by administration of BDNF (69).
Further, such effects may be due to changes in hippocampal gene
expression (70, 71). The general conclusion is that stressful post-
natal environment may add deterioration on young’s exposed to
prenatal alcohols. The specific interaction between prenatal alco-
hol and stressful post-natal environment however, has not been
sufficiently examined.
POST-NATAL ENVIRONMENTAL ENRICHMENT IN FASD
Prenatal alcohol causes FASD. Also, how prenatal alcohol may
manifest the development of FASD is becoming apparent. One
of the next logical questions in FASD research deals with the role
of post-natal environment. Most FASD children are born into an
environment of malnutrition and drug and nicotine abuse (72,73).
In addition, poor socio-economic lifestyles along-with neglectful
parenting, exacerbate the behavioral and cognitive abnormalities
so characteristic of FASD children. It has been hypothesized that
an enriched post-natal environment may lessen the severity of the
manifestation in a newborn diagnosed with FASD. An enriched
post-natal environment may involve intensive physical, cognitive,
and behaviorally challenging environments (74, 75). The repeated
exposure to counseling sessions and specialized classes with an aim
to develop verbal, math, and social skills helps ameliorate some,
if not all behavioral and cognitive deficits. While some interven-
tions manage to lessen stress and anxiety levels in FASD children,
cognitive disabilities still remain at large. However, such rehabili-
tative therapies have been unsuccessful in improving the spectrum
of ID in FASD. What is needed is a better understanding of the
molecular events that follow rehabilitative therapies in humans.
To this end, it will be desirable to answer the question: Do rehabil-
itative therapies target the very same affected molecular pathways
that cause FASD or do they have different molecular mechanisms?
Such questions are better explored using animal models.
What constitutes “rehabilitative therapies” in rodent models of
FASD? Ethanol exposed rats and mice that are subjected to phys-
ically and cognitively challenging environments (EE) tend to be
less stressed and have improved memory performance (76). Given
how fetal alcohol exposure affects neurodevelopment, it is possible
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FIGURE 1 | Proposed developmental model of cognitive ability in FASD
based on mouse models of prenatal alcohol exposure. It shows the effect
of prenatal alcohol (A) or control (C) under normal/non-enriched (NE) and
enriched (E) conditions during early post-natal development. It portrays the
effect of prenatal alcohol on epigenetic, gene expression, and metabolomic
alterations during neurodevelopment as well as the effect of post-natal
conditions on epigenetic, gene expression, and metabolomics during
post-natal development. The expected cognitive ability of the mice subjected
to the four treatment combinations (A–NE, A–E, C–NE, and C–E) is projected.
It suggests that the post-natal environment is capable of ameliorating (at least
partly) the effect of prenatal alcohol and other effects that may affect mental
ability of the newborn.
that the effectiveness of EE result from a targeted activation of
specific molecular mechanisms that modify brain structure and
function and are ultimately expressed as “rehabilitated” behaviors.
Compared to standard housing conditions (non-enriched) with
shoe-box sized cages and basic food and housing, enriched cages
tend to be much larger. The latter have toys of various shapes, sizes
and textures, tunnels, nesting material, heavy bedding, and access
to running wheels and ladders. The objects and their locations
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are changed weekly. Such environments facilitate mice to burrow,
climb, chew, run, and explore new objects and placements, thereby
engaging and developing cognitive processes. To eliminate stress
due to isolation and or lack of social interaction, all mice, whether
in standard or enriched cages are socially housed.
Our lab, amongst others has been interested in learning more
about the effects of a positive, enriched post-natal environment on
mice exposed to alcohol prenatally. Our first objective has been to
demonstrate that environmental enrichment can ameliorate some,
if not all of the behavioral and cognitive deficits that are character-
istic FASD phenotypes. Four groups of mice have been generated:
Control/Saline (C) mice living in enriched (CE) and non-enriched
(CNE) conditions and prenatal alcohol exposed mice (A) living in
enriched (AE) and non-enriched (ANE) conditions. Our results
show that FASD mice that have been exposed to environmental
enrichment (i) exhibit a fewer number of anxiety-like traits (as
evidenced by more time spent in the light-region of the light–dark
box and open-arms of the elevated-plus maze) and (ii) perform
relatively better in learning and memory tests (as evaluated by the
novel-object recognition and the Barnes maze). This experimental
design has also allowed us to establish that enrichment not only
ameliorates behavioral and cognitive deficits of affected mice (AE
versus ANE) but improves these characteristics in normal, healthy
control mice that had never been exposed to alcohol (CE versus
CNE). Group comparison has also shown that prenatal ethanol
exposure causes permanent and long-lasting damage to the devel-
oping brain. Further, the post-natal environmental enrichment is
successful in ameliorating these deficits only to a certain extent.
The mechanism involved in this amelioration is poorly understood
and deserves further research.
The long-lasting effects of environmental enrichment have
implicated changes in epigenetic machinery. Such results in con-
junction with other lines of evidence show that the DNA methyl-
transferases (DNMTs) and histone acetyltransferases (HATs) are
essential in neurodevelopment activities such as neural stem
cell proliferation, differentiation, and synaptic plasticity (77–79).
Work by Rampon et al. was among the first to show that DNMTs
are preferentially up-regulated in the brains of healthy mice that
have undergone environmental enrichment (80). While a num-
ber of genes involved in neuronal structure, neural plasticity,
and synaptic signaling were up-regulated, the highest levels of
induction was found in DNMTs. These enzymes are critical in
neural cell differentiation induced by nerve growth factors (80).
In 2011, Lopez-Atalaya et al. investigated the role of the his-
tone acetyltransferase CREB-binding protein (CBP) in the context
of environmental enrichment (81). CBP has been shown to be
involved in neural plasticity and memory processes in the brain.
Dysregulation of CBP is associated with a complex epigenetic
disorder known as Rubinstein–Taybi syndrome, characterized by
behavioral and cognitive deficits. CBP-deficient mice undergo-
ing environmental enrichment have ameliorated physiological and
behavioral deficits. In addition, multiple roles of CBP in neu-
rogenesis and neuroadaptation to environmental changes were
identified (81). Environmental enrichment has been shown to
cause a dramatic increase in IDNA levels of BDNF, with con-
comitant widespread changes in histone methylation at various
BDNF promoters and no change in the expression levels of several
brain-specific microRNAs (82). Various other studies have pointed
out the important role of BDNF in learning and memory processes
(83, 84), particularly how BDNF shapes the cognitive and stress-
response trajectory of neurodevelopment through interactions
with the HPA axis (85–88). Our lab and others are currently
investigating the effects of environmental enrichment on mice
following alcohol exposure in the context of BDNF and its associ-
ated epigenetic marks to gain a better understanding of how the
post-natal environment acts to ameliorate negative phenotypic
outcomes as a result of alcohol exposure.
SYNTHESIS AND FUTURE PERSPECTIVE
Most intellectual disabilities in children are caused by neurode-
velopmental aberrations. Often they involve complex interactions
of genes and environment over prenatal and post-natal periods.
For example, intellectual disabilities in FASD are caused by PAE
that disrupts neurodevelopment via alterations in gene expres-
sion. This affects a number of pathways that undergo changes
during ontogeny over time. Here, the primary effect of alcohol
covers cellular compromise and apoptosis, the expected toxic effect
of ethanol. It leaves a molecular footprint that is shared among
neurological disorders. The genes affected are related via hub mol-
ecules. More important, these results may last for life. We attribute
them to epigenetic changes. The epigenetic machinery affected
includes DNA methylation, miRNA, and histone modifications
(44). The results argue that epigenetic features are critical during
neurodevelopment. Any aberration in ongoing epigenetic marks at
any stage during neurodevelopment may result in intellectual dis-
abilities. It follows reports that have implicated epigenetic causes
in intellectual disabilities (89–91). Such a conclusion has far reach-
ing implications including prospect for an epigenetic therapy (92).
We anticipate that this will be a major challenge for the scientific
community in the next decade.
We argue that relatively long time course of neurodevelopment
offers an opportunity to apply potential epigenetic therapy in intel-
lectual disabilities. For example, a prenatal defect may be corrected
following birth during early post-natal development. At this stage,
developing brain is malleable. Also, it is responsive to variety of
mediators including drugs, care, and social interactions. As stated,
it is possible to partially ameliorate FASD deficits by post-natal
environmental enrichment in B6 mice. The current most logi-
cal mediator for any amelioration in humans appears to be the
early environment enrichment including cognitive therapy and
interactive schooling. It is considered most logical and effective.
Rodent research also suggests that animals raised under envi-
ronmentally enriched conditions exhibit relatively fewer stress-
and anxiety-like traits. Also, they have improved learning and
memory. Further, just like the effect of prenatal alcohol, the
recovery of FASD-related cognitive dysfunction due to post-natal
environment also involves epigenetic processes. Such results are
encouraging for the reversal of epigenetic marks. Although the
specific methods for this reversal are not apparent, rehabilita-
tive therapies and drug regimes that target epigenetic pathways
would provide a good starting point. To this end, the further
research should clarify two aspects of this research. First, what
is the relationship between DNA methylation, histone modifi-
cation and microRNA expression, brain structure and function,
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and intellectual ability including intellectual deficits in the FASD
model? Second, what are the genetic pathways and mechanisms
that might be targeted in future attempts to treat behavioral, cog-
nitive, and intellectual deficits associated with human fetal alcohol
exposure? The answer to such questions will have the potential to
identify suitable treatments for ID caused by neurodevelopmental
aberrations.
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